Home > Resources > Whitepapers > YOUR REFERENCE GUIDE TO THE ANALYSIS OF BIOPHARMACEUTICALS AND BIOMOLECULES

YOUR REFERENCE GUIDE TO THE ANALYSIS OF BIOPHARMACEUTICALS AND BIOMOLECULES

Biotherapeutics have enormous potential to improve human health. The number of approved protein and antibody therapeutics continues to grow around the world as this important therapeutic class addresses unmet medical needs. But discovery and development of biopharmaceuticals is difficult. You face a variety of challenges and must not only stay abreast of advances in knowledge and improvements in technology, but also navigate the maze of shifting government regulations.

Spotlight

Cellply

Cellply is a life-science company that develops in-vitro diagnostic platforms supporting personalized cancer treatment. Through the use of proprietary microtechnologies, diagnostic tests defining cell response to drug treatments are made available at the bedside. Results of the fully automated analysis guide anatomo-pathologists and oncologists in choosing the best drug therapy after cells from each patient have been exposed to several candidate drugs.

OTHER WHITEPAPERS

Microfluidics: Big developments on thesmall scale

whitePaper | February 23, 2023

Life sciences is a blanket term used to describe the study of all things relative to living organisms, such as biology, physiology, and biochemistry.

BLOCKCHAIN ENABLED GENOME SECURITY FROM THE MOMENT IT IS SEQUENCED

whitePaper | June 8, 2022

Sequencing of human genomes is fast becoming an affordable technology for general consumer.

Osmolality monitoring for UF/DF and CEXcapture of mAbs from mammalian cell cultures

whitePaper | July 25, 2022

The goal of each process step is to facilitate the production of a consistent product with high yield, quality, purity, and functionality. Throughout each step various Process Analytical Tools (PAT) are used to ensure quality and production metrics are maintained.

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Next Generation Therapies and related Life Sciences topics

whitePaper | January 16, 2022

All gene therapies insert engineered DNA/RNA into living cells to make or modify new proteins

A Cornerstone in the Supply Chain of Cell-based Therapies

whitePaper | February 15, 2023

The diverse therapeutic attributes of mesenchymal stromal cells (MSCs) lend to their rapid development as cellular therapeutics. These unique attributes include potent immu nomodulatory properties [1,2], the potential to differentiate into multiple cell lineages.